Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy ...
April 8, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
Volpara to Showcase AI Software for Breast Centers at NCBC 2024 ...
March 18, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...
Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest ...
January 16, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced ...
Lunit to Acquire Volpara: Scheme Implementation Agreement Signed
December 14, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution ...
November 22, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting ...
October 24, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
Lunit and Leeds Teaching Hospitals NHS Trust to Launch World's First ...
October 6, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, and Leeds ...
Lunit SCOPE IO Enhances Breast Cancer Analysis and Treatment by ...
September 22, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
AI Confirms Tracheal Tube Position on Chest Radiography
September 18, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR), an ar ...
Lunit's AI-Powered Mammography Analysis Solution Achieves Comparable ...
September 13, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has ...